Exact Mass: 684.1971266

2)-galactoside

5- [ (2-O-beta-D-Glucopyranosyl-beta-D-galactopyranosyl) oxy ] -3-hydroxy-2- (2-hydroxy-4-methoxyphenyl) -7,8-dimethoxy-4H-1-benzopyran-4-one

Limocitrol 3-neohesperidoside

Germanaism C

5,7,3-Trihydroxy-6,4,5-trimethoxyisoflavone 7-O-(6-glucosylglucoside)

Chrysosplenol C 6,4-diglucoside

3)-galactoside

7,4-Dihydroxy-3,5,6,8-tetramethoxyflavone 4-glucosyl-(1-

4)-glucoside

2-[2-[(4-O-beta-D-Galactopyranosyl-beta-D-glucopyranosyl)oxy]-4-hydroxy-5-methoxyphenyl]-5-hydroxy-3,7-dimethoxy-4H-1-benzopyran-4-one

Veronicafolin 3-glucosyl- (1->3) -galactoside

3,5,4-Trihydroxy-6,7,3-trimeoxyflavone 3-glucosyl- (1->3) -galactoside

(1S)-6-O-acetyl-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxo-4H-1-benzopyran-8-yl]-2-O-[(4-hydroxy-3,5-dimethoxyphenyl)carbonyl]-D-glucitol|hispidulin 8-C-(6-O-acetyl-2-O-syringoyl-beta-D-glucopyranoside)

(1S)-6-O-acetyl-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxo-4H-1-benzopyran-8-yl]-2-O-[(4-hydroxy-3,5-dimethoxyphenyl)carbonyl]-D-glucitol|hispidulin 8-C-(6-O-acetyl-2-O-syringoyl-beta-D-glucopyranoside)

C33H32O16 (684.1690272)

Clemochinenoside A|clemochinenoside-A

1,6-diacetoxy-4-hydroxy-1,2,9-trifuroyloxy-beta-dihydroagarofuran

Blepharismin B

C40H28O11 (684.1631538)

garciobioxanthone

C37H32O13 (684.1842822)

6-O-alpha-L-(4-O-trans-feruloyl)rhamnopyranosylcatalpol

3-O-Digalactoside-Eupatin

veronicafolin 3-digalactoside

6-O-alpha-L-(2-O-isoferuloyl)rhamnopyranosylcatalpol

4,4-O-di-beta-D-glucopyranosyl rosmarinic acid

6-O--catalpol|6-O-[alpha-L-(4-isoferuloyl)-rhamnopyranosyl]-catalpol|Scropheanosid II

andirolide E

C35H40O14 (684.241794)

COSMOSIIN HEXAACETATE

C33H32O16 (684.1690272)

Veronicafolin 3-glucosyl-(1->3)-galactoside

Quercetagetin 6,7,3-trimethyl ether 3-glucosyl-(1->3)-galactoside

7,4-Dihydroxy-3,5,6,8-tetramethoxyflavone 4-glucosyl-(1->3)-galactoside

5,2,4-Trihydroxy-3,7,5-trimethoxyflavone 2-galactosyl-(1->4)-glucoside

C34H36O15_(1S,2S,4S,5R,6R,7S,9R,12R)-12-Acetoxy-6-(acetoxymethyl)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0~1,6~]dodecane-4,5,7-triyl tri(3-furoate)

NCGC00384623-01_C34H36O15_(1S,2S,4S,5R,6R,7S,9R,12R)-12-Acetoxy-6-(acetoxymethyl)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0~1,6~]dodecane-4,5,7-triyl tri(3-furoate)

C18H56O10Si9 (684.1796796000001)

Citbismine C

2-[5,9-dihydroxy-2-(2-hydroxypropan-2-yl)-10-methoxy-11-methyl-6-oxo-1H,2H,6H,11H-furo[2,3-c]acridin-1-yl]-1-hydroxy-3,5,6-trimethoxy-10-methyl-9,10-dihydroacridin-9-one

C37H36N2O11 (684.2318986)

1,17-Dihydroxy octadecamethyl nonasiloxane

(Fmoc-Cys-OH)2

C36H32N2O8S2 (684.1599992)

PigMent Yellow 12

C36H34Cl2N6O4 (684.2018464)

Ferroheme c

C34H36FeN4O4S2-2 (684.1527246)

[(2S,3S)-3-hydroxy-3-(4-hydroxy-3-methoxyphenyl)-2-[4-[(E)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyprop-1-enyl]-2-methoxyphenoxy]propyl] (E)-3-hydroxy-3-(4-hydroxyphenyl)prop-2-enoate

C38H36O12 (684.2206656000001)

Ferroheme c

C34H36FeN4O4S2 (684.1527246)

A ferroheme coordination complex bearing 1-sulfanylethyl substituents at the 8- and 13-positions.

ADH-1 (trifluoroacetate)

C24H35F3N8O8S2 (684.1971266)

ADH-1 trifluoroacetate is an N-cadherin antagonist, which inhibits N-cadherin mediated cell adhesion.

Eplivanserin (hemifumarate)

C19H21FN2O2.1/2C4H4O4 (684.1696562)

Eplivanserin (SR-46349) hemifumarate is a potent, selective and orally active 5-HT2A receptor antagonist, with an IC50 of 5.8 nM in rat cortical membrane, and a Kd of 1.14 nM. Eplivanserin hemifumarate displays >20-fold selectivity more selective for 5-HT2A than 5-HT2B and 5-HT2C[1][2].

3-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-6,7-dimethoxychromen-4-one

5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxy-2-(2-hydroxy-4-methoxyphenyl)-7,8-dimethoxychromen-4-one

(1s,4as,7s,7as)-1-{[(2s,3r,4s,5s,6r)-6-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,7s,7as)-1-{[(2s,3r,4s,5s,6r)-6-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-7-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,6s,7s,7as)-1-{[(2s,3r,4s,5s,6r)-6-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-6-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,6s,7s,7as)-1-{[(2s,3r,4s,5s,6r)-6-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-6-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-7-methyl-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylic acid

3,5-dihydroxy-2-{[2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-4-yl 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

3,5-dihydroxy-2-{[2-(hydroxymethyl)-10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-4-yl 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate

(2s,3r,4r,5s,6s)-3,5-dihydroxy-2-{[(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-4-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(2s,3r,4r,5s,6s)-3,5-dihydroxy-2-{[(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl]oxy}-6-methyloxan-4-yl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate